Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Sales | revenue | 411.43M | 100.37% |
| Gross profit | profit | 253.25M | 268.74% |
| Total cost of sales | cost | 158.18M | 15.75% |
| Income from operations | profit | 223.11M | 370.64% |
| Operating expenses | cost | 30.15M | 41.70% |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | profit | 215.55M | 439.21% |
| Other income | revenue | 3.55M | 276.75% |
| Foreign exchange gain/loss, net | revenue | 498000 | 35.69% |
| Nonoperating income (expense) | profit | 7.55M | 1.68% |
| Net income | profit | 19.03M | -34.10% |
| Net income (loss) from continuing operations | profit | 164.65M | 576.50% |
| Income tax expense (benefit) | cost | 50.90M | 225.51% |
| Aggregate | profit | 11.60M | -1.34% |
| Net (loss) income from discontinued operations, net of taxes | revenue | 183.68M | 3952.08% |
| Fair value adjustments, net | revenue | 5.95M | 75.47% |
| Interest expense, nonoperating, total | cost | 5.66M | -50.35% |
| Segment | Value | YoY |
|---|---|---|
| Keno Hill | 1.70M | 70.00% |
| Others | 409.73M | 107.73% |
| Segment | Value | YoY |
|---|---|---|
| Gold | 56.98M | 81.69% |
| Others | 354.46M | 103.74% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cash and cash equivalents | assets | 587.55M | |
| Trade | assets | 215.53M | |
| Materials and supplies | assets | 56.13M | |
| Other current assets | assets | 28.04M | |
| Other, net | assets | 26.61M | |
| Product inventories | assets | 24.21M | |
| Current investments | assets | 19.57M | |
| Total current assets | assets | 957.64M | |
| Property, plant and equipment, net | assets | 2.12B | |
| Non-current investments | assets | 158.48M | |
| Other non-current assets | assets | 117.36M | |
| Operating lease right-of-use assets | assets | 18.43M | |
| Restricted cash and cash equivalents | assets | 1.17M | |
| Identifiable assets | assets | 3.38B | |
| Total liabilities | liabilities | 805.48M | |
| Total stockholders' equity | equity | 2.57B | |
| Accumulated deficit | liabilities | 203.82M | |
| Less treasury stock, at cost; june 30, 2025 - 8,768,372 and december 31, 2024 - 8,813,127 shares issued and held in treasury | assets | 36.98M | |
| Accumulated other comprehensive loss, net | liabilities | 5.49M | |
| Long-term debt including finance leases | liabilities | 262.65M | |
| Deferred tax liabilities | liabilities | 194.07M | |
| Liabilities, current | liabilities | 193.85M | |
| Accrued reclamation and closure costs | liabilities | 114.00M | |
| Other non-current liabilities | liabilities | 40.91M | |
| Aggregate | equity | 2.82B | |
| Accounts payable and accrued liabilities | liabilities | 97.86M | |
| Accrued taxes | liabilities | 44.89M | |
| Other current liabilities | liabilities | 15.07M | |
| Accrued payroll and related benefits | liabilities | 13.59M | |
| Accrued reclamation costs, current | liabilities | 12.40M | |
| Finance and operating leases | liabilities | 3.60M | |
| Other current liabilities | liabilities | 3.53M | |
| Accrued interest | liabilities | 2.91M | |
| Capital surplus | liabilities | 2.65B | |
| Common stock, $0.25 par value, authorized 1,250,000,000 shares; issued march 31, 2026 - 679,581,721 shares and december 31, 2025 - 679,220,408 shares | liabilities | 169.78M | |
| Series b preferred stock, $0.25 par value, 157,756 shares issued and outstanding, liquidation preference - $7,889 | liabilities | 39000 |
| Item | Value |
|---|---|
| Cash provided by operating activities of continuing operations | 182.92M |
| Cash provided by operating activities of discontinued operations | 11.32M |
| Item | Value |
|---|---|
| Net cash provided by (used in) investing activities of continuing operations | 174.44M |
| Net cash used in investing activities of discontinued operations | -8.80M |
| Item | Value |
|---|---|
| Net cash (used in) provided by financing activities of continuing operations | -5.13M |
| Net cash used in financing activities of discontinued operations | -8.43M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 242.73M |
| Cash and cash equivalents, end of period | 588.72M |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support